These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32767240)

  • 1. The Role of ALDH in the Metastatic Potential of Osteosarcoma Cells and Potential ALDH Targets.
    Belayneh R; Weiss K
    Adv Exp Med Biol; 2020; 1258():157-166. PubMed ID: 32767240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity.
    Wang L; Park P; Zhang H; La Marca F; Lin CY
    Int J Cancer; 2011 Jan; 128(2):294-303. PubMed ID: 20309879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfiram/copper targets stem cell-like ALDH
    Jin N; Zhu X; Cheng F; Zhang L
    J Cell Biochem; 2018 Aug; 119(8):6882-6893. PubMed ID: 29665144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
    Wang L; Park P; La Marca F; Than KD; Lin CY
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors.
    Rodriguez-Torres M; Allan AL
    Clin Exp Metastasis; 2016 Jan; 33(1):97-113. PubMed ID: 26445849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells.
    Vasiliou V; Thompson DC; Smith C; Fujita M; Chen Y
    Chem Biol Interact; 2013 Feb; 202(1-3):2-10. PubMed ID: 23159885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and Isolation of Cancer Stem Cells Using ALDH Activity Assay.
    Mele L; Liccardo D; Tirino V
    Methods Mol Biol; 2018; 1692():43-48. PubMed ID: 28986885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.
    Nomura M; Rainusso N; Lee YC; Dawson B; Coarfa C; Han R; Larson JL; Shuck R; Kurenbekova L; Yustein JT
    J Natl Cancer Inst; 2019 Nov; 111(11):1216-1227. PubMed ID: 30793158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a novel class of covalent inhibitor for aldehyde dehydrogenases.
    Khanna M; Chen CH; Kimble-Hill A; Parajuli B; Perez-Miller S; Baskaran S; Kim J; Dria K; Vasiliou V; Mochly-Rosen D; Hurley TD
    J Biol Chem; 2011 Dec; 286(50):43486-94. PubMed ID: 22021038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting aldehyde dehydrogenase enzymes in combination with chemotherapy and immunotherapy: An approach to tackle resistance in cancer cells.
    Al-Shamma SA; Zaher DM; Hersi F; Abu Jayab NN; Omar HA
    Life Sci; 2023 May; 320():121541. PubMed ID: 36870386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde dehydrogenase as a marker for stem cells.
    Moreb JS
    Curr Stem Cell Res Ther; 2008 Dec; 3(4):237-46. PubMed ID: 19075754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldehyde toxicity and metabolism: the role of aldehyde dehydrogenases in detoxification, drug resistance and carcinogenesis.
    Ahmed Laskar A; Younus H
    Drug Metab Rev; 2019 Feb; 51(1):42-64. PubMed ID: 30514131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics and specificity of human liver aldehyde dehydrogenases toward aliphatic, aromatic, and fused polycyclic aldehydes.
    Klyosov AA
    Biochemistry; 1996 Apr; 35(14):4457-67. PubMed ID: 8605195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation.
    Raha D; Wilson TR; Peng J; Peterson D; Yue P; Evangelista M; Wilson C; Merchant M; Settleman J
    Cancer Res; 2014 Jul; 74(13):3579-90. PubMed ID: 24812274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal Targets ALDH Positive Cancer Stem Cell and Alters the Phenotype of Highly Metastatic Osteosarcoma Cells.
    Mu X; Patel S; Mektepbayeva D; Mahjoub A; Huard J; Weiss K
    Sarcoma; 2015; 2015():784954. PubMed ID: 26819566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldehyde dehydrogenase 3A1 is robustly upregulated in gastric cancer stem-like cells and associated with tumorigenesis.
    Wu D; Mou YP; Chen K; Cai JQ; Zhou YC; Pan Y; Xu XW; Zhou W; Gao JQ; Chen DW; Zhang RC
    Int J Oncol; 2016 Aug; 49(2):611-22. PubMed ID: 27279633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldehyde dehydrogenases in cancer: an opportunity for biomarker and drug development?
    Pors K; Moreb JS
    Drug Discov Today; 2014 Dec; 19(12):1953-63. PubMed ID: 25256776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells.
    Croker AK; Allan AL
    Breast Cancer Res Treat; 2012 May; 133(1):75-87. PubMed ID: 21818590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldehyde dehydrogenases and cell proliferation.
    Muzio G; Maggiora M; Paiuzzi E; Oraldi M; Canuto RA
    Free Radic Biol Med; 2012 Feb; 52(4):735-46. PubMed ID: 22206977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay.
    Zhou L; Sheng D; Wang D; Ma W; Deng Q; Deng L; Liu S
    Cell Biol Toxicol; 2019 Apr; 35(2):161-177. PubMed ID: 30220009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.